Pharvaris N.V. Statistics
NASDAQ: PHVSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
31.28-0.38 (-1.20%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Pharvaris N.V. by the numbers
Pharvaris N.V. has a market capitalization of $2.21 billion based on 70.79M shares outstanding. With trailing EPS of $-3.13, Pharvaris N.V. is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 4.3% below its 50-day average and 0.6% below its 200-day average.
Average daily trading volume is 756.20K shares, or about $23.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PHVS valuation vs. peer median
| Metric | PHVS | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.21B | $2.21B | +0% |
| Avg. volume | 756.20K | 721.00K | +5% |
Peer median across 8 companies: NAMS, PRGO, LKFT, RCUS, HCM, PVLA, PBH, AUPH.
Valuation
- Market cap
- $2.21B
- EPS (TTM)
- $-3.13
- Shares outstanding
- 70.79M
Price and trading
- Previous close
- 31.66
- Open
- 31.19
- Day range
- 30.43 – 31.99
- 52-week range
- 23.15 – 43.25
- 52-week change
- +25.98%
- Beta
- —
- Volume
- 464.00K
- Average volume
- 756.20K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 2.21B
- Forward Pe
- -10.38
- Eps
- -3.13
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 43.25
- Week52 Low
- 23.15
- Avg Volume
- 756.20K
- Shares Outstanding
- 70.79M
- Ma50
- 32.70
- Ma200
- 31.46
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -27.68%
- Pct From52w Low
- 35.12%